Charles E. Nolan
- Developmental Neuroscience top 5%
- Transplantation top 5%
- Physiology top 5%
- Alzheimer's disease research and treatments 10
- Nitric Oxide and Endothelin Effects 3
- Pharmacology top 5%
-
- Drug Transport and Resistance Mechanisms 6
-
- Computational Drug Discovery Methods 5
-
- RNA regulation and disease 3
- Glycosylation and Glycoproteins Research 2
-
- Neuroscience and Neuropharmacology Research 3
-
- Endoplasmic Reticulum Stress and Disease 2
- Co-authors
- Firoze B. JungalwalaK. H. ChouJames E. FinleyK. RichterJoel B. SchachterLit‐Fui LauRobert B. NelsonLi Liu
- Journals
- Journal of Neurochemistry (5 papers)Journal of Pharmacology and Experimental Therapeutics (4 papers)Journal of Medicinal Chemistry (3 papers)
- Partner nations
- United StatesUnited KingdomSweden
In The Last Decade
Charles E. Nolan
27 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 92
- Developmental Neuroscience 143
- Transplantation 69
- Critical Care and Intensive Care Medicine 106
- Physiology 436
- Pharmacology 187
Countries citing papers authored by Charles E. Nolan
This map shows the geographic impact of Charles E. Nolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Nolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Nolan more than expected).
Fields of papers citing papers by Charles E. Nolan
This network shows the impact of papers produced by Charles E. Nolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Nolan. The network helps show where Charles E. Nolan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles E. Nolan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 6 | |
| 2 | 2018 | 15 | |
| 3 | 2016 | 59 | |
| 4 | 2013 | 10 | |
| 5 | 2012 | 18 | |
| 6 | 2012 | 24 | |
| 7 | 2012 | 44 | |
| 8 | 2011 | 19 | |
| 9 | 2010 | 39 | |
| 10 | 2008 | 11 | |
| 11 | 2007 | 312 | |
| 12 | 2004 | 14 | |
| 13 | 1999 | 15 | |
| 14 | 1997 | 70 | |
| 15 | 1993 | 13 | |
| 16 | 1992 | 14 | |
| 17 | 1992 | 10 | |
| 18 | 1991 | 10 | |
| 19 | 1990 | 31 | |
| 20 | 1976 | 70 |
About Charles E. Nolan
Charles E. Nolan is a scholar working on Developmental Neuroscience, Physiology and Transplantation, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (10 papers), Drug Transport and Resistance Mechanisms (6 papers), Computational Drug Discovery Methods (5 papers), Nitric Oxide and Endothelin Effects (3 papers), RNA regulation and disease (3 papers), Neuroscience and Neuropharmacology Research (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). The work is most often cited by research in Developmental Neuroscience (143 citations), Transplantation (69 citations) and Critical Care and Intensive Care Medicine (106 citations). Charles E. Nolan has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Firoze B. Jungalwala, K. H. Chou, James E. Finley, K. Richter, Joel B. Schachter, Lit‐Fui Lau, Robert B. Nelson, Li Liu, Lili Wang and Mathieu Herman. Their work appears in journals such as Journal of Neurochemistry, Journal of Pharmacology and Experimental Therapeutics, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Alzheimer s & Dementia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.